Diabetic-Check-up: DiaPat® DN-PROteom Test and DiaPat® KardiOM Test
Diabetes patients (type 1 and type 2) are especially concerned by chronic loss of renal function (diabetic nephropathy) but also from coronary artery disease (CAD). Patients with a diabetic metabolic status have an increased risk for cardiovascular diseases. If these vascular changes are not recognised and treated in time, there is a higher risk of suffering a heart attack or loss of renal function.
Analysing the urine sample, DiaPat® DN-PROteom Test and DiaPat® KardiOM Test is a non-invasive, riskless and reliable method that allows early diagnosis of diabetic nephropathy (DN) and coronary artery disease (CAD). Suitable therapy at this early stage can not only prevent or substantially delay onset of diabetic nephropathy, but also reduce the high infarction risk of diabetes patients.
The DiaPat® DN-PROteom Test and DiaPat® KardiOM Test enables the detection of:
- renal damage 3 to 5 years prior to the occurrence of clinical symptoms
- coronary artery disease 1-2 years before any overt indications become manifest
Advantages of the DiaPat® DN-PROteom Test and DiaPat® KardiOM Test:
- Painless (non-invasive urine sample)
- Riskless (sampling)
- Reliable (detection of both diabetic nephropathy and coronary artery disease with high accuracy)
Risk factors for diabetes patients:
- Lifestyle (Unbalanced diet, physical inactivity)
DiaPat® DN-PROteom Test and DiaPat® KardiOM Test includes:
Comparison of current methods
|Conventional cardiovascular diagnostics||Conventional renal diagnostics||One test - two areas of expertise|
|Renal function test Proteinuria test Sonography||DiaPat test combination DN-PROteom + KardiOM|
Due to the interaction of heart and kidneys, diseases of the renal and of the cardiovascular system create a vicious circle, leading to steadily worsening pathological changes in both systems (cardio-renal syndrome).
The detection of early stage renal impairment and of increased risk of cardiac infarction helps to extend a healthy life. Therapeutic strategies based on drugs, but also vitamins or physical exercise, prevent or delay the loss of renal function, which mandates dialysis and increases the risk for cardiac infarction ~30-fold.